Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

References for PMC Articles for PubMed (Select 20585136)

1.

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens.

Sandbulte MR, Gao J, Straight TM, Eichelberger MC.

Influenza Other Respir Viruses. 2009 Sep;3(5):233-40.

PMID:
21462400
2.

Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.

Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK.

Clin Infect Dis. 2010 May 1;50(9):1252-5. doi: 10.1086/651605.

3.

Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Mar;54(3):1102-10. doi: 10.1128/AAC.01417-09. Epub 2009 Dec 22.

4.

Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Aug 21;58(32):893-6.

5.

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.

Hurt AC, Holien JK, Parker M, Kelso A, Barr IG.

J Virol. 2009 Oct;83(20):10366-73. doi: 10.1128/JVI.01200-09. Epub 2009 Jul 29.

6.

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG.

Antiviral Res. 2009 Jul;83(1):90-3. doi: 10.1016/j.antiviral.2009.03.003. Epub 2009 Mar 24.

PMID:
19501261
7.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

8.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme.

Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.

9.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
10.

Human influenza A viruses isolated in South America: genetic relations, adamantane resistance and vaccine strain match.

Goñi N, Russi J, Cristina J.

Infect Genet Evol. 2009 Mar;9(2):229-34. doi: 10.1016/j.meegid.2008.11.004. Epub 2008 Nov 27.

PMID:
19095085
11.

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

Deyde VM, Okomo-Adhiambo M, Sheu TG, Wallis TR, Fry A, Dharan N, Klimov AI, Gubareva LV.

Antiviral Res. 2009 Jan;81(1):16-24. doi: 10.1016/j.antiviral.2008.08.008. Epub 2008 Oct 7.

PMID:
18835410
12.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

13.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
14.

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI.

J Infect Dis. 2007 Jul 15;196(2):249-57. Epub 2007 Jun 7.

15.

Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern?

Ansaldi F, Valle L, Amicizia D, Banfi F, Pastorino B, Sticchi L, Icardi G, Gasparini R, Crovari P.

J Prev Med Hyg. 2006 Mar;47(1):1-3. No abstract available.

PMID:
17061402
16.

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N, Komadina N.

Antiviral Res. 2007 Feb;73(2):112-7. Epub 2006 Aug 28.

PMID:
16963130
17.

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M.

Antimicrob Agents Chemother. 2006 Jul;50(7):2395-402.

18.
19.

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI.

JAMA. 2006 Feb 22;295(8):891-4. Epub 2006 Feb 2.

PMID:
16456087
20.

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI.

Lancet. 2005 Oct 1;366(9492):1175-81. Epub 2005 Sep 22.

PMID:
16198766
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk